Vitamin D Increases Serum Levels of the Soluble Receptor for Advanced Glycation End Products in Women With PCOS



Status:Completed
Conditions:Ovarian Cancer, Other Indications, Women's Studies, Gastrointestinal
Therapuetic Areas:Gastroenterology, Oncology, Other, Reproductive
Healthy:No
Age Range:16 - 48
Updated:8/25/2018
Start Date:July 2012
End Date:October 2013

Use our guide to learn which trials are right for you!

The purpose of this study is to investigate the mechanism that explain the beneficial
clinical effect of vitamin D treatment in women with PCOS.

Seventy-nine women with (n=22) or without (control; n=57) PCOS who were diagnosed with
vitamin D deficiency were enrolled. Sixty-three women were replaced with oral vit D3 for 8
weeks (16 with PCOS and 47 controls) and 16 women were not treated (6 with PCOS and 10
controls). Serum 25 hydroxy-vitamin D (25 OH-D), sRAGE, and AMH concentrations were measured
at baseline and after vit D3 supplementation in the treated group, and 8 weeks apart in the
non-treated group. Paired t-test, Wilcoxon signed-rank test, and Pearson correlation were
used as appropriate.

Main outcome measure(s): Changes in serum sRAGE and AMH concentrations following vit D3
replacement.

Inclusion Criteria:

- Vitamin D deficient premenopausal women

Exclusion Criteria:

- Pregnant women

- Women during their postpartum period

- Breastfeeding women

- Women taking any kind of exogenous hormones

- Women receiving any form of oral vitamin D replacement
We found this trial at
1
site
Brooklyn, New York 11219
?
mi
from
Brooklyn, NY
Click here to add this to my saved trials